Jackie Spinner of Columbia Journalism Review writes about how the Chicago Tribune’s series on the pharmaceutical industry came about. Spinner writes, “The three-part investigative project focuses on hidden interactions between prescription medicines that could have...
Fortune magazine reporter Jen Wieczner is one of five winners of the second-annual ASME Next Awards for Journalists Under 30. The winners will be honored at the Ellie Awards Annual Gala on Feb. 7...
Pacific Coast Business Times, a weekly business journal covering Ventura, Santa Barbara and San Luis Obispo counties in California, has an immediate opening for a smart, aggressive, experienced reporter to cover real estate, banking, law,...
The Sacramento Business Journal is seeking a reporter capable of establishing themselves as the go-to source of news, data and perspective on the health care industry in our region. The ideal candidate will be...
The Kansas City Star’s breaking news team is seeking a business reporter focused on health care. He or she would be expected to cover the health care business in Kansas City as well as...
May Ortega is the new technology and health care reporter at Albquerque Business First, an American City Business Journals newspaper. Ortega writes, “Breaking news, crime, education — I’ve covered a little of everything throughout my...
The Nashville Business Journal is seeking talented, aggressive and curious applicants for a critical role: the opportunity to cover the single-most important industry in a major metropolitan city experiencing unprecedented growth. You may know...
The Birmingham Business Journal is seeking a reporter to cover Birmingham’s huge health care community and its ever-growing technology and innovation scene. The ideal candidate will marry strong traditional journalism skills – source building,...
Ron Winslow, the deputy bureau chief for health and science news at The Wall Street Journal, left the paper on Friday as part of the recent buyout offers. Winslow has written more than 1,000...
Shares of Seattle Genetics Inc. plummeted on Tuesday after the company said four leukemia patients died in clinical trials of an experimental treatment, prompting the U.S. Food and Drug Administration to halt, or suspend enrollment...
